The Market
Insurance sits on both sides of the regulated outcomes ledger. Carriers are the defendant-side counterparty in the overwhelming majority of personal injury, commercial, and employment litigation, managing reserve adequacy and claims exposure across enormous portfolios. At the same time, insurance is increasingly a capital participant in its own right, through judgment preservation insurance, after-the-event cost insurance, and contingent-risk products that transfer litigation outcome risk to a carrier for a premium. Both roles depend on the same underlying capability: pricing the probability distribution of a legal outcome accurately enough to reserve or underwrite against it.
The two roles are converging rather than staying separate as the litigation finance and insurance markets mature. A carrier managing claims exposure and a specialty underwriter pricing contingent-risk coverage on litigation outcomes are, in an important sense, doing the same analytical work from opposite sides of the transaction, which is part of why insurance-industry risk governance practice is increasingly relevant to how legal asset intelligence itself should be built and audited.
Counterparties
Property and casualty carriers managing claims reserves and defense costs; specialty and excess carriers underwriting judgment preservation and ATE products; reinsurers providing capacity behind those specialty lines; claims adjusters and defense counsel executing day-to-day claims handling; and litigation funders and law firms who are, from the carrier's perspective, the counterparty whose claim or case the carrier is reserving against or insuring around.
Reinsurers occupy a distinct position worth noting on their own: they typically have no direct relationship with the underlying claim or claimant at all, and their risk view is built entirely from the ceding carrier's own reserving and underwriting discipline, which makes independent, verifiable outcome intelligence particularly valuable to a reinsurer evaluating a specialty legal-risk treaty it did not itself underwrite from the ground up.
What Decides Outcome, Duration, and Settlement
For a claims organization, the governing questions are reserve adequacy given the outcome distribution for a given claim type and venue, and the settlement-timing window that determines when early resolution is cheaper than continued defense cost accrual. For a specialty underwriter pricing judgment preservation or ATE coverage, the questions are the probability of an adverse judgment or cost award and the duration over which that risk must be carried, since duration risk is priced into these products as directly as outcome risk.
Portfolio-level reserve adequacy is a distinct question from any single claim's reserve, since a claims organization managing thousands of open files needs to know not just the expected value of each file but the correlation across files, whether a given judge's docket, a particular venue's jury trend, or a specific plaintiff's-bar referral pattern is producing correlated adverse development across what looks, file by file, like a diversified book.
How Criterica Serves This Market
Criterica Intelligence provides the outcome, duration, and settlement-window models that both claims organizations and specialty underwriters use to price risk from the opposite side of the same case that a litigation funder is financing. Criterica Capital participates in insurance-adjacent capital structures through its fund capital platform, providing carriers, reinsurers, and other institutional capital partners exposure to underwriting-intelligence-governed legal asset structures through LP, co-investment, NAV, and warehouse facility formats. Criterica Group's integrity standard is written to be legible to insurance-industry risk governance specifically, cross-walked against model-risk management guidance that federal banking regulators and the Basel Committee already require of regulated financial institutions, so that an insurer evaluating a legal-asset-backed structure can apply a familiar governance lens.
Correlation and concentration modeling across a claims book, not just single-file valuation, is treated as a core deliverable for insurance counterparties specifically, since portfolio-level reserve adequacy is where an insurer's real risk exposure sits.
Data: What Exists, What Does Not
Claims-level reserve and payout data inside carrier systems is extensive but almost entirely proprietary and not shared across the industry, which is precisely why independent, court-record-based outcome intelligence has value to carriers rather than being redundant with what they already hold internally. Public data on judgment preservation and ATE product performance is minimal industry-wide, since these are still comparatively young product lines with limited claims history.
Court-record-based outcome intelligence is, by construction, independent of any single carrier's internal claims data, which is what allows it to serve as a cross-check on a carrier's own reserving assumptions rather than simply reproducing what the carrier's own systems already show.
Regulatory filings that carriers and reinsurers already make to state insurance departments, including statutory reserve disclosures, provide a partial public window into aggregate claims development by line of business, but that data is reported at a level of aggregation far too coarse to inform any single claim's reserve, which is the precision gap independent outcome intelligence is positioned to close.
Discuss Insurance
Capital partners, law firms, insurers, and institutional buyers evaluating this market.